Literature DB >> 4115345

Assessment of prognosis in patients with malignant melanoma.

R M Mackie, D C Carfrae, A J Cochran.   

Abstract

Entities:  

Mesh：

Year:  1972        PMID： 4115345     DOI： 10.1016/s0140-6736(72)91854-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Letter: "Prophylactic" regional lymph node dissection.

Authors:  H C Polk; B S Linn
Journal:  Ann Surg       Date:  1974-08       Impact factor: 12.969

2.  Conjunctival melanomas: prognostic factors a review and an analysis of a series.

Authors:  J B Crawford
Journal:  Trans Am Ophthalmol Soc       Date:  1980

3.  Recurrent malignant melanoma: effect of adjuvant immunotherapy on survival.

Authors:  P B McCulloch; P B Dent; M Blajchman; W M Muirhead; R A Price
Journal:  Can Med Assoc J       Date:  1977-07-09       Impact factor: 8.262

Review 4.  Management of the regional lymph nodes in patients with cutaneous malignant melanoma.

Authors:  A J Cochran; D R Wen; D L Morton
Journal:  World J Surg       Date:  1992 Mar-Apr       Impact factor: 3.352

5.  Factors prognostic for survival in patients with malignant melanoma spread to the regional lymph nodes.

Authors:  C Callery; A J Cochran; D J Roe; W Rees; S D Nathanson; J K Benedetti; R M Elashoff; D L Morton
Journal:  Ann Surg       Date:  1982-07       Impact factor: 12.969

6.  Computer-assisted measurement of primary tumor area is prognostic of recurrence-free survival in stage IB melanoma patients.

Authors:  Brooke E Rosenbaum; Christine N Schafer; Sung Won Han; Iman Osman; Hua Zhong; Nooshin Brinster
Journal:  Mod Pathol       Date:  2017-07-21       Impact factor: 7.842
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.